(Picture: CEO Jae Joon Lee(left) explaining
the company's AI medical image reading solution to the Vice Minister of Science
and ICT)
(Date: July 30, 2021)
Crescom Co., Ltd. (CEO Jae Joon Lee),
specializing in artificial intelligence analysis solutions for musculoskeletal
medical data, announced that it was finally selected for the ‘AI convergence
medical image reading system construction project’ hosted by the Health Insurance
Review and Assessment Service and the Information and Communication Industry
Promotion Agency. For this project, Crescom, Idot, and JLK companies were
finally selected.
Crescom formed a consortium with Seoul
National University Boramae Hospital, Seoul National University Bundang
Hospital, and Korea University Anam Hospital to develop artificial intelligence
(AI) solutions for diagnosis and examination of knee arthritis for three years.
The developed solution is used to support the diagnosis of knee degenerative
arthritis in the medical field and the review of the HIRA.
As a company selected for this project, AI
solutions were demonstrated at the opening ceremony of the ‘Artificial
Intelligence Convergence AI+X Project Medical Data Utilization Demonstration
Lab’ held at the Health Insurance Review and Assessment Service Headquarters in
Wonju, Gangwon-do, on the 28th. In this event, Prime Minister Bu Gyeom Kim,
National Assembly member Kwang Jae Lee, and Ki Heon Song, as well as major
officials from the Ministry of Science and ICT, the Ministry of Health and
Welfare of South Korea, the Ministry of Food and Drug Safety(MFDS), the Health
Insurance Review and Assessment Service(HIRA), and the National IT Industry
Promotion Agency (NIPA) attended the event to experience the solution
demonstrations of participating companies. and communicated with entrepreneurs.
Crescom's patented technology leads
'MediAI-BA' which is integrated the strengths of existing bone age reading
methods GP and TW3 growth plate inspection artificial intelligence solution and
'MediAI-FX' which is the artificial intelligence fracture detection solution.
These solutions can help with timely, quick and accurate reading in the medical
field.
‘MediAI-BA’ has been confirmed to be useful in the medical field in clinical trials for approval by the Ministry of Food and Drug Safety, and is currently helping to analyze the age of growth plates in children in more than 100 hospitals in Korea. ‘MediAI-FX’ can detect scaphoid fractures that cause serious sequelae when left unattended although the fractures are usually difficult to find out. The wrist fracture detection AI solution is currently in the final stage of clinical trials.
Crescom CEO Jae Joon Lee said, “Based on the support of the Ministry of Science and ICT and the Health Insurance Review and Assessment Service, we want to be helpful in the medical field and medical examination, and we will do our best to advance into the global market so that it can be widely used not only in Korea but also in overseas markets.”